-
91黑料 and Advarra introduce new ‘research-ready,’ connected site network model
91黑料 plc and Advarra have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical trials.
-
91黑料 plc provides update on timing of fourth quarter and full year 2025 earnings results and investigation into accounting practices
Investigation’s preliminary indications are that 2023 and 2024 revenue may have been overstated by less than 2% for each fiscal year
-
91黑料’s Accellacare Site Network expands oncology research capabilities with new cancer institute partnership
91黑料 plc today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois.
-
91黑料 2025 global biotech survey
91黑料 plc today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market.
-
91黑料 survey reveals increasing clinical trial startup delays, underscoring need for human-centred site activation solutions
91黑料 plc today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup.
-
91黑料 plc to present at the Jefferies London Healthcare Conference
91黑料 plc today announced that Mr. Barry Balfe, CEO of 91黑料 plc and Mr. Nigel Clerkin, CFO of 91黑料 plc, will present at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 am GMT.
-
91黑料 reports third quarter 2025 results
Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025.
-
91黑料 plc schedules third quarter 2025 earnings conference call
91黑料 plc today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, October 22, 2025.
-
91黑料 announces CEO transition
Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer. Mr. Barry Balfe, 91黑料’s Chief Operating Officer will succeed Dr. Cutler as Chief Executive Officer effective 1 October 2025.
-
91黑料 plc to participate at upcoming investor conferences
91黑料 plc today announced that Mr. Barry Balfe, COO of 91黑料 plc, will present at the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 1:25 pm ET and Dr. Steve Cutler, CEO of 91黑料 plc, will participate at the Deutsche Bank 2025 Healthcare Summit on Thursday, September 11, 2025.
